mVPDL
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for mVPDL, covering 2018-07-24 to 2018-07-24. Get the full timeline:
Most recent: Clinical Trial Update: Rituximab+mVPDL for CD20(+) Adult Acute Lymphoblastic Leukemia [Phase 2]